Purified anti-TAL1 Antibody

<strong>Purified anti-TAL1 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015696_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> Purified anti-TAL1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Valge-Archer VE, Osada H, Warren AJ, Forster A, Li J, Baer R, Rabbitts TH. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8617-21._x000D_ 2: Cheng JT, Hsu HL, Hwang LY, Baer R. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues Oncogene. 1993 Mar;8(3):677-83._x000D_ 3: Sanda T, Leong WZ. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia Exp Hematol. 2017 Sep;53:7-15._x000D_ 4: Hoang T, Lambert JA, Martin R. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming Curr Top Dev Biol. 2016;118:163-204._x000D_ 5: Smith C, Goyal A, Weichenhan D, Allemand E, Mayakonda A, Toprak U, Riedel A, Balducci E, Manojkumar M, Pejkovska A, M√ºcke O, Sollier E, Bakr A, Breuer K, Lutsik P, Hermine O, Spicuglia S, Asnafi V, Plass C, Touzart A. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer Haematologica. 2023 May 1;108(5):1259-1271._x000D_ 6: Thielemans N, Demeyer S, Mentens N, Gielen O, Provost S, Cools J. TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia Haematologica. 2022 Oct 1;107(10):2304-2317._x000D_ 7: Tan TK, Zhang C, Sanda T. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia Int J Hematol. 2019 Jan;109(1):5-17._x000D_ 8: Smith C, Touzart A, Simonin M, Tran-Quang C, Hypolite G, Latiri M, Andrieu GP, Balducci E, Dourthe M√â, Goyal A, Huguet F, Petit A, Ifrah N, Baruchel A, Dombret H, Macintyre E, Plass C, Ghysdael J, Boissel N, Asnafi V. Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL Mol Cancer. 2023 Jan 18;22(1):12._x000D_ 9: Baer R. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia Semin Cancer Biol. 1993 Dec;4(6):341-7._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31493871">10: Wu Y, Hu Y, Yu X, Zhang Y, Huang X, Chen S, Li Y, Zeng C. TAL1 mediates imatinib-induced CML cell apoptosis via the PTEN/PI3K/AKT pathway Biochem Biophys Res Commun. 2019 Nov 5;519(2):234-239. </a>_x000D_ _x000D_ <strong>Products Related to Purified anti-TAL1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>